The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

The Widal test involves collecting a blood sample and testing it for antibodies against Salmonella typhi and related serotypes.

No, the Widal test specifically detects antibodies against Salmonella typhi and is not used to diagnose other infections.

Positive results indicate exposure to Salmonella typhi, suggesting current or past infection, while negative results indicate no significant antibody response.

Recent vaccination against typhoid fever or certain medications may interfere with the accuracy of Widal test results.

The Widal test provides supportive evidence for diagnosing typhoid fever but is often used in conjunction with clinical symptoms and other diagnostic tests for confirmation.

A TMT test, or treadmill test, evaluates heart function during exercise to detect heart conditions.

Individuals experiencing chest pain, at risk for heart disease, or preparing for cardiac evaluation.

Patients walk on a treadmill while heart rate, blood pressure, and ECG are monitored.

Yes, it is supervised by cardiologists to ensure safety during exercise.

It suggests insufficient blood flow to the heart during exercise, indicating possible coronary artery disease.